SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
0.7700
+0.0010 (0.13%)
At close: Feb 2, 2026, 4:00 PM EST
0.7700
0.00 (0.00%)
Pre-market: Feb 3, 2026, 4:06 AM EST
SciSparc Revenue
SciSparc had revenue of $1.31M in the twelve months ending September 30, 2025, up 187.98% year-over-year. In the year 2024, SciSparc had annual revenue of $1.31M, down -54.64%.
Revenue (ttm)
$1.31M
Revenue Growth
+187.98%
P/S Ratio
2.57
Revenue / Employee
$653,000
Employees
2
Market Cap
3.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.31M | -1.57M | -54.64% |
| Dec 31, 2023 | 2.88M | 1.53M | 113.73% |
| Dec 31, 2022 | 1.35M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSPRC News
- 20 hours ago - SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA - GlobeNewsWire
- 20 hours ago - Neurothera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA - TheNewswire
- 7 days ago - SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization - GlobeNewsWire
- 20 days ago - SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity - GlobeNewsWire
- 21 days ago - SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders' Equity Non-Compliance - GlobeNewsWire
- 25 days ago - Neurothera Labs Announces Results of AGM - TheNewswire
- 4 weeks ago - SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects - GlobeNewsWire
- 4 weeks ago - Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects - TheNewswire